PLAT and COVID-19: Levels of VWF-Ag, tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 antigen (PAI-1) antigen, and soluble thrombomodulin (sTM) were also reported to be associated with poor outcomes in COVID19 patients (Andrianto et al., 2021).